Formycon (DB: FYB)

Last close As at 23/02/2024

61.30

−0.20 (−0.33%)

Market capitalisation

677m

Edison Investment Research is terminating coverage on Formycon. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

Formycon — H121 update: Future markets take shape

Healthcare | Update

Formycon — FY20 results – core progress on key projects

Healthcare | Update

Formycon — Two submissions and two Phase III trials in 2021

Healthcare | Update

Formycon — FY19 results – strong position, new projects

Share Price Performance

Financials

Edison Investment Research is terminating coverage on Formycon. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Thematics

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free